Charles Corbett
Family Medicine · Memphis, TNNPI 1619039526
Payments from drug & device makers
Across 469 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- Amarin Pharma, Inc.$1K
- GSK$550
- Lilly USA, LLC$504
- Bayer$445
- plus $2K from 13 others
What the payments were for
- Food & beverage$7,974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $1,604 |
| AstraZeneca | 88 | $1,516 |
| Amarin Pharma, Inc. | 55 | $1,009 |
| GSK | 37 | $550 |
| Lilly USA, LLC | 29 | $504 |
| Bayer | 22 | $445 |
| Sanofi-aventis U.S. LLC | 22 | $429 |
| Abbott | 19 | $346 |
| Boehringer Ingelheim | 20 | $319 |
| Kowa Pharmaceuticals America, Inc. | 25 | $314 |
| Merck | 13 | $196 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $192 |
| Johnson & Johnson | 10 | $149 |
| Amgen(2 entities) | 7 | $116 |
| Exact Sciences | 7 | $106 |
| Pfizer | 4 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| AbbVie(2 entities) | 2 | $39 |
| Dermira, Inc. | 1 | $12 |
How this compares
$7,974 in reported general payments places this provider in the 85th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 23 | $54,746 |
| FarxigaDapagliflozin Propanediol | 35 | $38,703 |
| OzempicSemaglutide | 19 | $36,228 |
| Xigduo XrDapaglifloz Propaned/Metformin | 26 | $32,521 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $18,848 |
| JardianceEmpagliflozin | 12 | $18,210 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $14,417 |
| LinzessLinaclotide | 14 | $14,284 |
| EliquisApixaban | 12 | $13,156 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 31 | $3,144 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $2,988 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 40 | $2,239 |
| Atorvastatin Calcium | 170 | $1,923 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 56 | $1,334 |
| Atenolol-ChlorthalidoneAtenolol/Chlorthalidone | 32 | $1,009 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $504 | $54,74623 claims |
| AstraZenecaFarxiga | $1,516 | $38,70335 claims |
| Novo NordiskOzempic | $1,604 | $36,22819 claims |
| GSKTrelegy Ellipta | $550 | $18,84820 claims |
| Boehringer IngelheimJardiance | $319 | $18,21012 claims |
| MerckJanumet | $196 | $14,41711 claims |
| AbbVieLinzess | $39 | $14,28414 claims |
| PfizerEliquis | $66 | $13,15612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Memphis
- Amanda MillerMemphis$171K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.